| Celgene Corporation | 100.5700 / +0.76% |
| Date/Time | 10/11 / 22:00 |
| Chg. / Chg.(%) | 0.7600 / +0.76% |
| Bid | 100.2200 / 200 |
| Ask | 100.9500 / 200 |
| Open | 100.2500 |
| Previous Close | 99.8100 |
| High | 100.9600 |
| Low | 99.9800 |
| Volume [USD] | 190,569,314.6564 |
| Volume [Units] | 3,698,436 |
| Price fixings | 17866 |
| ISIN | US1510201049 |
| Security | CELG |
| Exchange | NASDAQ |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| TradeGate | 91.080 |  |
53 |
| Vienna Globa.. | 91.31 | |
0 |
| Frankfurt | 91.2200 | |
0 |
| Berlin | 91.24 | |
0 |
| Düsseldorf | 91.18 | |
0 |
| Hamburg | 91.29 | |
0 |
| München | 91.18 | |
0 |
| Lang & Schwa.. | 91.160 | |
|
| Stuttgart | 91.280 | |
|
| gettex | 91.260 | |
|
| NASDAQ | 100.5700 | |
3,698,436 |
| Cboe US | 100.55 | |
303,957 |
| IEX | 100.57 | |
31,740 |
| Xetra | 91.00 | 2,043 | |
| London Inter.. | 100.41 | 144 | |
| SIX Swiss Ex.. | 91.90 | ||
| SIX Swiss Ex.. | 89.40 | ||
| Mexico | 1,928.00 | 43 |
News
- Agios to Present Data from AG-270 Phase 1 Dose-Escalation Study in Patients with MTAP-Deleted Tumors in a Proffered Papers Oral Presentation and Poster Session at the AACR-NCI-EORTC International Conference
10/09/2019 / 13:00 - GlobeNewswire - Autolus Announces Changes to Executive Leadership Team
10/08/2019 / 14:00 - GlobeNewswire - 2019 Natural Killer Cells Therapeutics Report: Market to Grow from $1.4 Billion in 2018 to $5.1 Billion by 2026
10/01/2019 / 13:27 - GlobeNewswire - BeiGene Announces Clinical Data on Tislelizumab and Pamiparib Presented at the European Society for Medical Oncology (ESMO) Congress 2019
09/30/2019 / 12:00 - GlobeNewswire - AnaptysBio to Present at the Cantor Fitzgerald Global Healthcare Conference
09/27/2019 / 12:30 - GlobeNewswire
Real-time